All In MedTech

Device Trial Radar · NCT05371795

Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device

Research Study: Tattooing of Skin Landmarks in Radiotherapy: Comparison Between the System Traditional and Comfort Marker 2.0® (COMFORTATTOO)

Last checked: Nov 20, 2026Latest source record: Jun 10, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

100

Actual

Start

Oct 18, 2021

Primary completion

Mar 11, 2022

Study completion Sep 2022

Sponsor

Lead sponsor
Instituto Portugues de Oncologia, Francisco Gentil, PortoAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 12, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Comparison on radiotherapy skin set-up markings with lancets versus Comfort Marker 2.0®

Conditions

  • Radiotherapy
  • Tattooing

Interventions

  • Comfort Marker 2.0Device

    The set-up markings are created during the simulation session, after the CT simulation is acquired. For the experimental group, patients' markings are tattooed using an electric marking device developed for set-up marking, the Comfort Marker 2.0® (CM), designed by CIVCO medical solutions, using the 0.2mm deep application depth and the brand-included black pigment. After cleaning the excess ink, if the tattooing was considered unsuccessful, the process was repeated. Markings arrangement followed our departmental protocol. No limit on the maximum number of cutaneous reference points is specified.

  • LancetsDevice

    The set-up markings are created during the simulation session, after the CT simulation is acquired. For the control group, patients' markings are tattooed using a 28-gauge disposable lancet and india ink. After cleaning the excess ink, if the tattooing was considered unsuccessful, the process was repeated. Markings arrangement followed our departmental protocol. No limit on the maximum number of cutaneous reference points is specified.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patients' comfortTime frame: Day 1
  2. EffectivenessTime frame: up to 7 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Instituto Português de Oncologia do Porto Francisco Genti

    Porto, Portugal

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.